Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 4:9:226.
doi: 10.3389/fendo.2018.00226. eCollection 2018.

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency

Jolanta Sawicka-Powierza  1   2 , Jerzy Konstantynowicz  3 , Ewa Jablonska  4 , Beata Zelazowska-Rutkowska  5 , Wojciech Jelski  6 , Pawel Abramowicz  3 , Caroline Sasinowski  7 , Slawomir Chlabicz  1
Affiliations

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency

Jolanta Sawicka-Powierza et al. Front Endocrinol (Lausanne). .

Abstract

Objective: Both vitamin D and K2 are involved in a number of metabolic processes, including bone metabolism; however, associations between the vitamins are not fully understood. The aim of the study was to evaluate serum concentrations of 25-hydroxyvitamin D [25(OH)D] in adult patients receiving long-term acenocoumarol (AC) treatment.

Participants and methods: In this cross-sectional study, 58 Caucasian patients (31 women, 27 men) with a median age of 65 years receiving long-term AC therapy were evaluated and compared with 35 age- and gender-matched healthy controls. The AC treatment was used due to recurrent venous thromboembolism (34.5%), atrial fibrillation (31%), or mechanical heart valve prostheses (34.5%). Medical records and a questionnaire were used to obtain information about chronic diseases, smoking habits, and the duration of therapy and weekly dose of AC. Anthropometric measurements were performed, and serum concentration of 25(OH)D and total alkaline phosphatase (ALP) activity were measured.

Results: Among the 58 patients receiving long-term AC treatment, a high proportion (46.6%) demonstrated significant vitamin D deficiency with concentrations of 25(OH)D lower than 20 ng/mL. The median concentration of 25(OH)D in subjects receiving AC was significantly lower compared to the control group [20.4 (17.4; 26.1) vs. 28.2 (24; 32.7); p < 0.001]. No differences were found between women and men receiving AC therapy. In patients receiving AC, a negative correlation was found between the concentration of 25(OH)D and the weekly dose of AC (r = -0.337, p = 0.01). Patients with concentrations of 25(OH)D < 20 ng/mL were found to have a significantly higher median dose of AC, compared to those with concentrations of 25(OH)D ≥ 20 ng/mL [21 (17; 31) vs. 17 (12; 28); p = 0.045].

Conclusion: In conclusion, treatment with AC is associated with low 25-hydroxyvitamin D levels, although the path leading to this phenomenon is not entirely clear. Long-term administration of AC in adults may increase the risk of chronic vitamin D deficiency, thus, effective supplementation of vitamin D in these individuals needs careful consideration.

Keywords: acenocoumarol; chronic disease; long-term treatment; vitamin D deficiency; vitamin K antagonist.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The significant difference in percent distribution of 25(OH)D levels in subjects receiving acenocoumarol treatment and controls (n = 93).
Figure 2
Figure 2
Correlation between concentration of 25(OH)D (ng/mL) and a weekly dose of acenocoumarol (mg) in studied patients (n = 58).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hollis BW. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int (1996) 58:4–5.10.1007/BF02509538 - DOI - PubMed
    1. Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry (1971) 10:2799–804.10.1021/bi00790a023 - DOI - PubMed
    1. Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, et al. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha, 25-dihydroxyvitamin D3. Bone (2007) 40:1517–28.10.1016/j.bone.2007.02.024 - DOI - PubMed
    1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 96:1911–30.10.1210/jc.2011-0385 - DOI - PubMed
    1. Silver J, Levi R. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int Suppl (2005) 95:S8–12.10.1111/j.1523-1755.2005.09501.x - DOI - PubMed

LinkOut - more resources